IGF1 promotes the development and cytotoxic activity of human NK cells [37], therefore the reduction of this protein by the augmented expression of IGF2 by miR-483-5p [91], or by the direct targeting of IGF1 by miR-483-3p [92,93], provide a protection to cancer cells by suppressing NK cells activity. Here, IGF1 is linked to cancer.